Targets Conference Showcases Exciting Data from Clinical Trials of Innovative Cancer Therapeutics
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
Category: Featured
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held this year at the Hynes Convention Center in...
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...
Sports are often referred to as a metaphor for life. But, for ESPN reporter Holly Rowe, sports are quite...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
The women bustle around a warm, colorful kitchen, making tamales for an upcoming family party. A woman in her...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Pediatric cancer, while rare, is a devastating diagnosis that is estimated to affect over 11,000 children in the United...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved wrapped...